Investment Approach
The Health Sciences Portfolio seeks long-term growth of capital by
investing at least 80% of total assets in common stocks of companies engaged in the research, development, production, or distribution of products or services related to health care, medicine, and the life sciences. The portfolio focuses primarily on U.S. stocks but may also invest up to 35% of assets in foreign securities. While the fund may purchase small-company stocks, its primary focus should be large and mid-size companies. It is intended for long-term investors who can accept the higher risks inherent in a portfolio that concentrates on a volatile area of the stock market.
Management
Kris H. Jenner is a portfolio manager and health care stock analyst for T. Rowe Price and a vice president of T. Rowe Price Group, Inc. He is chairman of the Investment Advisory Committee for the Health Sciences Fund and is a member of the committees for several of the
firm's growth-oriented portfolios.
Mr. Jenner joined the firm in 1997 and has five years of previous investment experience as well as a medical background as an MD. He earned a BS in chemistry from the University of Illinois, a D.Phil. from Oxford University, and an MD from the Johns Hopkins School of Medicine.
Before investing, carefully consider the investment objectives, risks, fees, and charges. This and other important information about the policy and investment options are contained in the prospectus, which may be obtained from your financial professional or at www.omfn.com. Read the prospectus carefully and consider these factors before investing.
Beacon Advisor flexible premium variable annuity contract is offered on a group or individual basis as determined by state availability. Group Certificate OM FCDVA BA -C2007 and Individual Form OM FCDVA BA 2007, et al. Optional provisions and riders have limitations, restrictions and additional charges except where noted, and are subject to state availability. For the exact terms and conditions, refer to the contract.
